Male circumcision decreases high-risk human papillomavirus viral load in female partners: A randomized trial in Rakai, Uganda

International Journal of Cancer

Volumn 133, Issue 5, 2013, Pages 1247-1252

  Davis, Mitzie Ann ^a,b   Gray, Ronald H ^b,c   Grabowski, Mary K ^b   Serwadda, David ^c,d   Kigozi, Godfrey ^c   Gravitt, Patti E ^b,e   Nalugoda, Fred ^c   Watya, Stephen ^d   Wawer, Maria J ^b,c   Quinn, Thomas C ^c,f,g   Tobian, Aaron A R ^c,f  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

^d MAKERERE UNIVERSITY   (Uganda)

^e PERDANA UNIVERSITY   (Malaysia)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

cervical cancer; HIV; human papillomavirus; linear array band intensity; male circumcision; sexually transmitted infections; Uganda; viral load; viral shedding

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; CIRCUMCISION; CONTROLLED STUDY; FEMALE; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UGANDA; VAGINA SMEAR; VIRUS LOAD;

CERVICAL CANCER; HIV; HUMAN PAPILLOMAVIRUS; LINEAR ARRAY BAND INTENSITY; MALE CIRCUMCISION; SEXUALLY TRANSMITTED INFECTIONS; UGANDA; VIRAL LOAD; VIRAL SHEDDING;

ADOLESCENT; ADULT; CIRCUMCISION, MALE; FEMALE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; RISK; UGANDA; VIRAL LOAD;

EID: 84879230913     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28100     Document Type: Article

References (25)

1. de Sanjose S, Diaz M, Castellsague X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007; 7: 453-9.
2. Moscicki AB, Ellenberg JH, Farhat S, et al. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type. J Infect Dis 2004; 190: 37-45.
3. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27.
4. Dalstein V, Riethmuller D, Pretet JL, et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 2003; 106: 396-403.
5. Ylitalo N, Sorensen P, Josefsson AM, et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 2000; 355: 2194-8.
6. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
7. Tobian AA, Gray RH,. The medical benefits of male circumcision. JAMA 2011; 306: 1479-80.
8. Giuliano AR, Lazcano E, Villa LL, et al. Circumcision and sexual behavior: factors independently associated with human papillomavirus detection among men in the HIM study. Int J Cancer 2009; 124: 1251-7.
9. Tobian AA, Serwadda D, Quinn TC, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med 2009; 360: 1298-309.
10. Auvert B, Sobngwi-Tambekou J, Cutler E, et al. Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in orange farm, South Africa. J Infect Dis 2009; 199: 14-9.
11. Tobian AA, Kong X, Gravitt PE, et al. Male circumcision and anatomic sites of penile high-risk human papillomavirus in Rakai, Uganda. Int J Cancer 2011; 129: 2970-5.
12. Gray RH, Serwadda D, Kong X, et al. Male Circumcision Decreases Acquisition and Increases Clearance of High-Risk Human Papillomavirus in HIV-Negative Men: A Randomized Trial in Rakai, Uganda. J Infect Dis 2010; 201: 1455-62.
13. Backes DM, Bleeker MC, Meijer CJ, et al. Male circumcision is associated with a lower prevalence of human papillomavirus-associated penile lesions among Kenyan men. Int J Cancer 2012; 130: 1888-97.
14. Wawer MJ, Tobian AA, Kigozi G, et al. Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda. Lancet 2011; 277: 209-18.
15. Castellsague X, Bosch FX, Munoz N, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002; 346: 1105-12.
16. Wilson L, Gravitt P, Tobian A, et al. Male circumcision reduces penile high risk human papillomavirus (HPV) viral load in a randomized clinical trial in Rakai, Uganda. Sex Transm Infect 2013; doi: 10.1136/sextrans-2012-050633.
17. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007; 369: 657-66.
18. Serwadda D, Wawer MJ, Shah KV, et al. Use of a hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus. J Infect Dis 1999; 180: 1316-9.
19. Tobian AA, Kigozi G, Gravitt PE, et al. Human papillomavirus incidence and clearance among HIV-positive and HIV-negative men in Rakai, Uganda. AIDS 2012; 26: 1555-65.
20. Cogliano V, Baan R, Straif K, et al. Carcinogenicity of human papillomaviruses. Lancet Oncol 2005; 6: 204.
21. Wentzensen N, Gravitt PE, Long R, et al. Human papillomavirus load measured by linear array correlates with quantitative PCR in cervical cytology specimens. J Clin Microbiol 2012; 50: 1564-70.
22. Xi LF, Hughes JP, Edelstein ZR, et al. Human Papillomavirus (HPV) type 16 and type 18 DNA loads at baseline and persistence of type-specific infection during a 2-year follow-up. J Infect Dis 2009; 200: 1789-97.
23. Tobian AA, Gray RH,. Male foreskin and oncogenic human papillomavirus infection in men and their female partners. Future Microbiol 2011; 6: 739-45.
24. Bleeker MC, Hogewoning CJ, Berkhof J, et al. Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads. Clin Infect Dis 2005; 41: 612-20.
25. Gravitt PE,. The known unknowns of HPV natural history. J Clin Invest 2011; 121: 4593-9.